GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 47 filers reported holding GAMIDA CELL LTD in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,925,482 | -47.8% | 2,840,274 | -2.1% | 0.35% | -45.3% |
| Q2 2023 | $5,600,424 | +143.9% | 2,901,774 | +2.4% | 0.64% | +123.2% |
| Q1 2023 | $2,295,895 | +277.4% | 2,834,438 | +501.1% | 0.28% | +247.6% |
| Q4 2022 | $608,307 | +1420.8% | 471,556 | +1786.2% | 0.08% | +1540.0% |
| Q3 2022 | $40,000 | -51.8% | 25,000 | +25.0% | 0.01% | -37.5% |
| Q1 2022 | $83,000 | -53.4% | 20,000 | -71.4% | 0.01% | -52.9% |
| Q4 2021 | $178,000 | – | 70,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,858,558 | $18,323,000 | 2.20% |
| Stonepine Capital Management, LLC | 443,507 | $2,843,000 | 1.49% |
| Healthcare Value Capital, LLC | 75,000 | $481,000 | 0.96% |
| Laird Norton Wetherby Trust Company, LLC | 529,103 | $3,391,000 | 0.35% |
| Rock Springs Capital Management LP | 2,107,000 | $13,506,000 | 0.27% |
| FIRST MIDWEST BANK TRUST DIVISION | 276,724 | $1,774,000 | 0.24% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $682,000 | 0.18% |
| Platform Technology Partners | 45,375 | $291,000 | 0.12% |
| PREMIER ASSET MANAGEMENT LLC | 110,660 | $709,000 | 0.10% |
| Virtus ETF Advisers LLC | 34,842 | $223,000 | 0.09% |